These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 33713370)

  • 21. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
    Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
    Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
    Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
    Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
    Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone-induced Somnambulism: A Case Report and Brief Review of Literature.
    Najmi A; Siddiqui F; Ray A; Jhaj R; Sadasivam B
    Cureus; 2020 Mar; 12(3):e7238. PubMed ID: 32284914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase.
    De Las Cuevas C; Sanz EJ; Villasante-Tezanos AG; de Leon J
    Expert Opin Drug Metab Toxicol; 2023 Feb; 19(2):57-74. PubMed ID: 36920343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions.
    Hägg S; Bate A; Stahl M; Spigset O
    Drug Saf; 2008; 31(8):685-94. PubMed ID: 18636787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Effects of 30 Antipsychotics on Risk of Catatonia: An Analysis of the WHO Pharmacovigilance Database.
    Da Costa J; Very E; Rousseau V; Virolle J; Redon M; Taïb S; Revet A; Montastruc F
    J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36516322
    [No Abstract]   [Full Text] [Related]  

  • 32. Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase
    Kaguelidou F; Valtuille Z; Durrieu G; Delorme R; Peyre H; Treluyer JM; Montastruc F; Chouchana L
    Drug Saf; 2023 Jan; 46(1):77-85. PubMed ID: 36459374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database.
    Nguyen LS; Cooper LT; Kerneis M; Funck-Brentano C; Silvain J; Brechot N; Hekimian G; Ammirati E; Ben M'Barek B; Redheuil A; Gandjbakhch E; Bihan K; Lebrun-Vignes B; Ederhy S; Dolladille C; Moslehi JJ; Salem JE
    Nat Commun; 2022 Jan; 13(1):25. PubMed ID: 35013204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.
    Lertxundi U; Ruiz AI; Aspiazu MÁ; Domingo-Echaburu S; García M; Aguirre C; García-Moncó JC
    Clin Neuropharmacol; 2015; 38(3):69-84. PubMed ID: 25970275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis.
    Gouverneur A; Sanchez-Pena P; Veyrac G; Salem JE; Bégaud B; Bezin J
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):271-276. PubMed ID: 34436707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis.
    Buhagiar K; Jabbar F
    Clin Drug Investig; 2019 Mar; 39(3):253-273. PubMed ID: 30675684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase.
    Roselli A; Khouri C; Roustit M; Blaise S; Cracowski JL
    Dermatol Surg; 2019 Dec; 45(12):1517-1528. PubMed ID: 30829775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep-related eating disorder induced by olanzapine.
    Paquet V; Strul J; Servais L; Pelc I; Fossion P
    J Clin Psychiatry; 2002 Jul; 63(7):597. PubMed ID: 12143918
    [No Abstract]   [Full Text] [Related]  

  • 40. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
    Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
    Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.